biotech

NanOlogy Sees ‘Encouraging Signs’ for Its Microparticle Drug Delivery in Nonoperable Lung Cancer Patients

by | Nov 20, 2022

Fort Worth-based NanOlogy has completed the enrollment of 18 patients in a Phase 2a trial for its proprietary particle drug delivery with standard-of care therapy in nonoperable lung cancer patients.

Lung cancer is the most lethal form of cancer with the highest mortality rate, according to the biotech, which aims to improve the treatment of cancer with its tumor-directed technology....

MORE
JLL’s DFW Life Science Snapshot: What’s Driving the North Texas Biotech Boom
by | Oct 4, 2022
The North Texas biotech boom just keeps booming—and a new "DFW Life Science Snapshot" from JLL shows why. From the Biotech+ Hub at Pegasus Park to a string of accelerators to local universities, DFW Airport, and more, here's a deep dive into what's behind the boom. "We are showing up in the rankings and in the data," says Mike Rosa of the Dallas Regional Chamber. "It results in more opportunities and more looks for us."
MORE
Form Bio Spins Out of Colossal Bioscience to Offer Scientists the ‘Missing Piece’
by | Sep 27, 2022
Dallas-based Colossal Biosciences, the de-extinction company behind plans to bring back the woolly mammoth and thylacine, developed its own software solution "after reviewing everything available on the market." Now it's sharing the platform with the launch of Form Bio.

The spinout's technology tools can help drive the “entire molecular revolution” that is occurring in the life sciences and biotech space, in addition to bolstering the Lone Star state as a hub for the industry, says Chief Strategy Officer Claire Aldridge.
MORE
Runway Growth Capital Adds to Life Science Team With New Dallas Managing Director
by | Aug 20, 2022
Brannon Morisoli will join the team at a time when life science is booming in North Texas. Most recently, Dallas-Fort Worth ranked for the first time in the "Top 20 U.S. metros for life science" 2022 report by CommercialEdge. 
MORE
At the Fourth Annual iC3 Life Science Summit at UT Arlington on Oct. 10, 2017 recipient Lyda Hill will present the award. To register for the summit, visit www.bionorthtx.org. [Illustration: bestbrk/istockphoto]

Dallas-Fort Worth Makes List of Top 20 Life Science Metros

by | Jul 8, 2022
See how the region ranked.
MORE
Dallas-Founded Biopharma Firm Raises $120M to Expand its Pipeline
by | Jun 29, 2022
ReCode Therapeutics, a biopharmaceutical startup using a non-viral lipid nanoparticle delivery platform for gene therapies, has closed a $120 million extension to a funding round it raised last year to help bring its lead programs to human trials and “follow the science” to target new diseases. With a research team working out of BioLabs' life sciences facility at Pegasus Park, ReCode aims to grow its global team from about 70 to 100 over the next year.
MORE
From right: DRC's Jorge Varela (far right) moderated a panel of industry experts including biotech C-level executive Hua Tu, Health Wildcatters CEO and co-founder Hubert Zajicek, and LH Capital Director Matt Crommett.
‘From a Trickle to a Waterfall’: How Biotech’s Flow is Growing in DFW
by | May 24, 2022
"It takes time" to establish a track record, Jorge Varela says, and the region is starting to see a series of biotech successes and spinoffs that will elevate the region's profile as a biotech hub.

According to a panel of experts at Urban Land Institute's 2022 spring meeting, here are factors drawing biotech to DFW.
MORE
Southwestern Medical Foundation President and CEO Kathleen Gibson has joined the board of nonprofit LaunchBio. [Image: Southwestern Medical Foundation; istockphoto]
Southwestern Medical Foundation President and CEO Joins LaunchBio Board
by | Apr 29, 2022
LaunchBio, a life science and biotech nonprofit that expanded to North Texas in 2021, has announced four new board members, including Dallas-based Kathleen Gibson, along with a new board chair.

LaunchBio is working to accelerate the entrepreneurial support network in the region through collaborations with BioLabs, Lyda Hill Philanthropies, J. Small Investments, BioNTX, DLA Piper, and others.
MORE

TCU School of Medicine Is Building a New Campus in Fort Worth’s Medical District

by | Mar 1, 2022
The project will kick off with a four-story, approximately 100,000-square-foot medical education building, which TCU says will serve as an “academic hub” for around 240 students and hundreds of faculty and staff members, after its planned completion in 2024. At the new campus, TCU School of Medicine's innovative curriculum will continue—with students focused on major drivers of medicine's future, including AI, genomics, and advanced monitoring technology.
MORE
With New Funding and CEO, This Southlake Biotech is Looking to Solve Kidney Disease
by | Feb 16, 2022
Renibus Therapeutics, which focuses on treatments for acute and chronic kidney diseases, announced closing a $35 million Series A funding round. Its new CEO, Frank Stonebanks, says "Renibus has arrived at a critical inflection point in its commitment to transform the prevention and treatment of kidney diseases."
MORE
New Evolve Biologics Plant in Sachse Will Add 300 Jobs, Reinforcing DFW as a Biotech Hub
by | Dec 6, 2021
Mississauga, Ontario-based Evolve Biologics is a producer of plasma-derived therapeutics. The firm's CEO says the new, state-of-the-art, 200,000-SF Sachse facility "will be the foundation of our future growth and global strategy," with the capacity to process 1 million liters of plasma annually and a planned expansion to 2 million liters.
MORE
Dallas-Based Vaxxinity Prepares for $100M IPO; Aims to Turn Immune Systems Into ‘Antibody Factories’
by | Nov 8, 2021
Vaxxinity's COVID-19 vaccine candidate is "super safe and mild and doesn’t bring recipients down for a couple of days with flu-like symptoms," says the company's co-founder and CEO, Mei Mei Hu. Unlike mRNA vaccines from Modern and Pfizer, Vaxxinity says its protein peptide-based platform is based on tech that led to a vaccine for foot-and-mouth disease in livestock.
MORE

OncoNano Expands Research Collaboration With UT Southwestern to Advance New Cancer Therapies

by | Sep 22, 2021
Southlake-based OncoNano Medicine uses pH-sensitive nanoparticle technology to "light up" cancer for real-time surgical imaging. The multi-year collaboration will seek to uncover new cancer therapies that can benefit from OncoNano's technology. OncoNano raised $50 million in Series B funding in June.
MORE
Nominate Now: BioNTX Dennis K. Stone Award Recognizes Positive Impact in North Texas Biotech and Life Science Research
by | Sep 14, 2021
Deadline for nominations is Friday, September 17. The 2021 award, sponsored by BioLabs at Pegasus Park, will be presented on September 30 at the iC3 Life Science Summit. The impact that Dr. Dennis K. Stone left on the DFW biotech industry is, without doubt, immeasurable, says BioNTX. Past recipients of the award that honors his memory are Phil Ralston, Lyda Hill, Darlene Boudreaux, Paul Dorman, and Hubert Zajicek.
MORE
Signature Biologics Expands Its Irving Footprint With a New Manufacturing and R&D Headquarters
by | Aug 25, 2021
There, Signature Biologics will manufacture perinatal-derived products that improve the body's natural healing processes in wound, musculoskeletal, and pain management applications.
MORE
Renovations Begin for BioLabs’ December Opening at Pegasus Park
by | Aug 10, 2021
A mid-December opening is planned for BioLabs' first central U.S. location in Dallas. Inside the Biotech+ Hub at Pegasus Park, BioLabs will serve as the key operator of the biotech laboratory and 37,000-square-foot flexible life science coworking facility.
MORE